Hunan Xinyan Electronic Commerce Co., Ltd. – Trademark Portfolio

Entity Type: 99

Hunan Xinyan Electronic Commerce Co., Ltd. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include X&Y LIFE. The owner is based in Changsha,Hunan.

Rm 104-107-195,Bldg.A,Xuri Dongsheng

Home,No.427,Jiayu Rd.,Furong Dist.

Changsha,Hunan 41001 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

X&Y LIFE
X&Y LIFE
Registered 2022

Trademark Classifications

Hunan Xinyan Electronic Commerce Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Hunan Xinyan Electronic Commerce Co., Ltd. have?

Hunan Xinyan Electronic Commerce Co., Ltd. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does Hunan Xinyan Electronic Commerce Co., Ltd. file in?

Hunan Xinyan Electronic Commerce Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are Hunan Xinyan Electronic Commerce Co., Ltd.'s most well-known trademarks?

Hunan Xinyan Electronic Commerce Co., Ltd.'s registered trademark portfolio includes well-known marks such as X&Y LIFE. These are among 1 currently registered trademark in the portfolio.

What is Hunan Xinyan Electronic Commerce Co., Ltd.'s trademark registration success rate?

Hunan Xinyan Electronic Commerce Co., Ltd. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.